tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), BioNTech SE (BNTX) and Zimmer Biomet Holdings (ZBH)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Molina Healthcare (MOHResearch Report), BioNTech SE (BNTXResearch Report) and Zimmer Biomet Holdings (ZBHResearch Report).

Molina Healthcare (MOH)

Cantor Fitzgerald analyst Sarah James maintained a Buy rating on Molina Healthcare yesterday and set a price target of $406.00. The company’s shares closed last Thursday at $381.49, close to its 52-week high of $391.21.

According to TipRanks.com, James is a 5-star analyst with an average return of 11.3% and a 68.3% success rate. James covers the Healthcare sector, focusing on stocks such as Tenet Healthcare, CVS Health, and Centene.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Molina Healthcare with a $402.14 average price target, representing a 10.2% upside. In a report released today, Goldman Sachs also maintained a Buy rating on the stock.

See today’s best-performing stocks on TipRanks >>

BioNTech SE (BNTX)

Canaccord Genuity analyst William Maughan maintained a Buy rating on BioNTech SE yesterday and set a price target of $168.00. The company’s shares closed last Thursday at $94.10, close to its 52-week low of $88.00.

According to TipRanks.com, Maughan is a 5-star analyst with an average return of 50.2% and a 60.0% success rate. Maughan covers the Healthcare sector, focusing on stocks such as Olema Pharmaceuticals, Century Therapeutics, and Bicycle Therapeutics.

BioNTech SE has an analyst consensus of Hold, with a price target consensus of $119.33, a 25.3% upside from current levels. In a report issued on January 31, Leerink Partners also maintained a Buy rating on the stock.

Zimmer Biomet Holdings (ZBH)

In a report released yesterday, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings, with a price target of $130.00. The company’s shares closed last Thursday at $123.04.

According to TipRanks.com, Cronin is a 3-star analyst with an average return of 19.9% and a 71.4% success rate. Cronin covers the Healthcare sector, focusing on stocks such as Vicarious Surgical, REPRO-MED Systems, and TELA Bio.

Zimmer Biomet Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $132.86, which is a 10.1% upside from current levels. In a report released yesterday, Needham also maintained a Hold rating on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MOH:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles